Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  CYANOTECH CORP    CYAN

CYANOTECH CORP (CYAN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

CYANOTECH : Michael A. Davis Named Chairman of the Board of Directors of Cyanotech

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2011 | 02:10pm CEST

Michael A. Davis has been elected as Chairman of the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). He replaces Gregg Robertson, who resigned in late 2010.

Mr. Davis was Vice-Chairman of the Board and has been a Director of Cyanotech since March 2003.

"Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years," said Brent Bailey, President and CEO. "We look forward to his continuing support and leadership as Chairman of the Board."

Mr. Davis, a private Investor and major shareholder of Cyanotech since 1994, is also President of Skywords Family Foundation and a Director of Canobie Films, Inc.

About Cyanotech -- Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®--all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.

Cyanotech Corporation
Bruce Russell, 310-559-4955 x101


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CYANOTECH CORP
10:43pCYANOTECH : Q4 2018 Earnings Broadcast transcript
PU
07:02pCYANOTECH : NELHA secures $2M federal award to develop desalination technologies
AQ
02:08pCYANOTECH : State of Hawaii Secures $2 Million in Federal Funding for Solar Desa..
AQ
06/16CYANOTECH : Production woes drag Cyanotech to loss
AQ
06/15CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
06/15CYANOTECH : Reports Financial Results for the Fourth Quarter and Fiscal Year 201..
BU
04/16CYANOTECH CORPORATION (NASDAQ : CYAN) Files An 8-K Other Events
AQ
04/13CYANOTECH CORP : Other Events (form 8-K)
AQ
02/06CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
02/06CYANOTECH : Reports Financial Results for the Third Quarter of Fiscal Year 2018
BU
More news
News from SeekingAlpha
06/20Cyanotech Corporation (CYAN) CEO Mawae Morton on Q4 2018 Results - Earnings C.. 
06/15Cyanotech reports Q4 results 
04/18CYANOTECH : An Opportune Moment To Buy 
04/16Midday Gainers / Losers (04/16/2018) 
04/16HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (04/16/2018) 
Chart CYANOTECH CORP
Duration : Period :
CYANOTECH CORP Technical Analysis Chart | CYAN | US2324373016 | 4-Traders
Managers
NameTitle
Mawae Morton Chief Executive Officer & Director
Michael A. Davis Chairman
Gerard J. Watts Chief Operating Officer
Jolé Eileen Deal CFO, Secretary, Treasurer & VP-Administration
Gerald R. Cysewski Vice Chairman & Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
CYANOTECH CORP3.35%0
CSL LIMITED37.16%64 716
BIOGEN-6.86%61 623
ALEXION PHARMACEUTICALS4.12%27 125
GRIFOLS9.89%18 984
BIOMARIN PHARMACEUTICAL7.23%16 897